Under construction – not a live service
Sign in
Taking people in SwedenNo phase

Tests extra mouth care to ease treatment sores in head and neck cancer patients

Tests extra mouth care in adults having treatment for head and neck cancer.

Plain-language title generated from the registry record
Registry title: Evaluation of an Oral Care Programme for Head and Neck Cancer Patients

Key facts

Where
Gothenburg and Jönköping, SwedenSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT03481647, who can take part

Where in Sweden

  • Institute of odontologyGothenburg, SwedenNo longer taking part
  • Lanssjukhuset RyhovJönköping, SwedenTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Göteborg University
Trial code
NCT03481647
Record updated
20 April 2025
Original description
This study will evaluate the effect of an intensified oral care programme on prevalence, severity and duration of mucositis in patients undergoing treatment for cancer in the head and neck region.Read full original descriptionShow less

Evaluation of an Oral Care Programme for Patients Undergoing Treatment for Head and Neck Cancer Regarding Mucositis, Oral Health, Epigenetic Modifications, Patient-related Factors, Quality of Life and Health Economy

This study will evaluate the effect of an intensified oral care programme on prevalence, severity and duration of mucositis in patients undergoing treatment for cancer in the head and neck region.

Patients in the control group get professional oral care once a week.

Inclusion: Patients scheduled to receive full dose of curative RT including major salivary glands in the radiation field.

Exclusion: Patients with recurrent cancer; Patients with severe cognitive impairment.

ClinicalTrials.gov NCT03481647